Amgen is a multinational biopharmaceutical corporation that discovers, develops, manufactures, and delivers human therapeutics across oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other therapeutic areas. Beyond its core commercial operations, Amgen deploys capital through venture and growth equity investments to advance innovation in biotechnology and life sciences, including partnerships with specialized funds focused on emerging cancer therapies and related research platforms. The firm structures its investment activities to identify promising scientific approaches and early-stage companies that complement its long-term pipeline strategy while contributing...
Asset class
Impact theme
Investment geographies
